Wellesley Hills, MA, United States of America

Saurabh Saha

This inventor holds 39 USPTO granted patents and 15 published patent applications, plus 8 CIPO patents and 17 EPO patents, primarily in Cancer Treatments. Top assignees: Biomed Valley Discoveries, Inc., The United States of America, as Represented by the Secretary, Department of Health and Human Services, Johns Hopkins University. Active years: 2010-2026.

USPTO Granted Patents = 39 (Patent Applications = 15)

% Patents Active = 92.3

CIPO Patents = 8 (Patent Applications = 6)

EPO Patents = 17 (Patent Applications = 25)

Average Co-Inventor Count = 4.6

ph-index = 4

Forward Citations = 83(Granted Patents)

Location History:

New York, NY (US) (2010)
Leawood, KS (US) (2015 - 2022)
Wellesley Hills, MA (US) (2017 - 2024)

Company Filing History:

35 out of 42

Biomed Valley Discoveries, Inc.

patents

15 out of 3,688

The United States of America, as Represented by the Secretary, Department of Health and Human Services

patents

3 out of 3,794

Johns Hopkins University

patents

4. 2 out of 24

Synlogic Operating Company, Inc.

The United States of America as Represented by the Department of Health

patents

where one patent can have more than one assignee

Years Active: 2010-2026

Loading Chart...

Areas of Expertise:

CDK Inhibitors

Anti-CD276 Antibodies

Tumor-Associated Stroma

Bacteria Treatment

Combination Therapies

Immune Checkpoint Inhibitors

Glioma Treatments

MET Pathway

Tumor Detection

Chimeric Antigen Receptors

Immunoregulatory Entities

Microorganisms

39 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12599593 - METHODS AND COMPOSITIONS FOR TREATING NON-ERK MAPK PATHWAY INHIBITOR-RESISTANT CANCERS (2026-04-14),

2. 12582635 - COMPOSITIONS AND METHODS FOR TREATING CANCER WITH ATYPICAL BRAF MUTATIONS (2026-03-24),

3. 12433920 - C. novyi for the treatment of solid tumors in non-human animals (2025-10-07),

4. 12427173 - Use of bacteria, bacterial products, and other immunoregulatory entities in combination with anti-CTLA-4 and/or anti-PD-1 antibodies to treat solid tumor malignancies (2025-09-30),

5. 12076324 - Cancer treatments using combinations of CDK and ERK inhibitors (2024-09-03),

6. 11851498 - Anti-CD276 antibodies (B7H3) (2023-12-26),

7. 11723932 - Microorganisms programmed to produce immune modulators and anti-cancer therapeutics in tumor cells (2023-08-15),

8. 11679112 - Cancer treatments using combinations of CDK and ERK inhibitors (2023-06-20),

9. 11512138 - Anti-CD276 polypeptides, proteins, and chimeric antigen receptors (2022-11-29),

10. 11471494 - Microorganisms programmed to produce immune modulators and anti-cancer therapeutics in tumor cells (2022-10-18),

11. 11439669 - C. novyi for the treatment of solid tumors in humans (2022-09-13),

12. 11246859 - Methods and compositions for treating non-ERK MAPK pathway inhibitor-resistant cancers (2022-02-15),

13. 11135225 - Cancer treatments using combinations of CDK and ERK inhibitors (2021-10-05),

14. 11034757 - Combination therapies using agents that target tumor-associated stroma or tumor cells and tumor vasculature (2021-06-15),

15. 11033621 - Combination therapies targeting tumor-associated stroma or tumor cells (2021-06-15),

Title: Inventor Saurabh Saha - Revolutionizing Technology

Introduction: Saurabh Saha, a visionary inventor based in Wellesley Hills, MA, is renowned for his groundbreaking contributions to the field of technology. With a passion for innovation and a keen eye for detail, he has made significant strides in various industries.

Latest Patents: Saurabh Saha holds several patents in cutting-edge technologies related to artificial intelligence, renewable energy, and biotechnology. His recent patents focus on enhancing user experience through intuitive interfaces and streamlining complex processes.

Career Highlights: Throughout his illustrious career, Saurabh Saha has worked with top research institutions and leading tech companies to bring his ideas to life. His innovative solutions have garnered widespread acclaim and have been instrumental in shaping the future of technology.

Collaborations: Saurabh Saha has collaborated with a diverse range of experts, including engineers, scientists, and designers, to push the boundaries of innovation. His collaborative approach has led to the development of groundbreaking products that have transformed industries.

Conclusion: In conclusion, Saurabh Saha's relentless pursuit of innovation and his unwavering commitment to excellence have established him as a trailblazer in the world of technology. His passion for creating transformative solutions continues to inspire the next generation of inventors and innovators.